Boehringer Ingelheim Roxane Inc voluntarily recalled Acarbose Tablets 50 mg on April 2, 2015, after the FDA announced the drugs were subpotent due to out-of-specification assay results. The recall affects specific lots distributed nationwide and in Puerto Rico.
How to tell if you have it
- Brand: Roxane Laboratories
- Product: Acarbose Tablets 50 mg
- NDC: 0054-0141-20 (10 x 10 Unit Dose Tablets per Blister Pack)
- NDC: 0054-0141-25 (100 count Bottles)
- Lot # 460073A Exp 04/2016
- Lot # 460073B Exp 04/2016
The hazard
The firm received an out of specification result for Assay, meaning potency was below specification at the 9 month stability time point. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has 12 other recalls on record since 2012-11-05. Other recent recalls of similar products include Apotex Paxil CR 37.5mg Tablets Recall: Failed Stability Testing (2026-08-13), AvKARE Rosuvastatin Tablets 10mg Recall: Dissolution Issue (2025-12-31), and Ascend Laboratories recalls Amlodipine/Olmesartan tablets with low drug content (2026-07-08).